Traveler's Constipation

November 24, 2023 updated by: Sebastian Hansen, Herlev Hospital
The occurence of traveler's constipation is sparsely covered in the medical litterature. This study aims to determine the gastrointestinal-related discomforts related to traveling on a trip to Turkey.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Traveler's constipation, which is characterized by the more hard and less frequent stools, is sparsely covered in the medical litterature. Only a few studies have examined this problem and the actual occurrence and extent of this problem is not known. Hypotheses about why travel constipation occurs are, among other things, about changed circadian rhythm due to jet lag, changed schedules and tight sanitary conditions. Other factors such as dehydration, change in cabin pressure and the content of the in-flight food in connection with flights have not been investigated.

The research project aims to clarify changes in the test subjects' bowel habits as well as other gastrointestinal-related discomforts in connection with a flight abroad with only an hour's time difference and without the consumption of flight food.

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Danmark
      • Herlev, Danmark, Denmark, 2730
        • Herlev Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Can understand danish and is able to answer the questionnaires
  • Given written consent

Exclusion Criteria:

  • History of intestinal resection
  • Medically treated intestinal disease
  • IBS at baseline

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Flight
The intervention is the flight to turkey and home to Denmark again.
The participants are flying to turkey and back home. The flights are the intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stool frequency
Time Frame: 14 days
The investigators are sending questionnaires to the participants of the study to decide wether the stool frequency decreases after flight to turkey. No scale used, simply time and number.
14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bristol Stool Chart.
Time Frame: 14 days
The investigators are evaluating if the stool becomes less liquid indicating a prolonged transition time. On er Likert scale from 1-7, 7 being most wet.
14 days
VAS-IBS: Visual Analog Scale for Irritable Bowel Syndrome
Time Frame: 14 days
Scale from 0-100 describing gastrointestinal bloating, pain and discomfort. 0 being good and 100 being bad
14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2023

Primary Completion (Actual)

May 20, 2023

Study Completion (Actual)

May 20, 2023

Study Registration Dates

First Submitted

April 27, 2023

First Submitted That Met QC Criteria

November 24, 2023

First Posted (Estimated)

December 5, 2023

Study Record Updates

Last Update Posted (Estimated)

December 5, 2023

Last Update Submitted That Met QC Criteria

November 24, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • F-23025419

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Constipation

Clinical Trials on Flight

Subscribe